JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 56.35
+0.85 (1.53%)
Jan 2, 2026, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 178.11 billion as of January 2, 2026. Its market cap has increased by 92.35% in one year.
Market Cap
178.11B
Enterprise Value
124.56B
Revenue
71.34B
Ranking
n/a
PE Ratio
34.21
Stock Price
56.35
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 178.11B, a decrease of -48.22%. That is a compound annual growth rate of -12.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 178.11B | 98.17% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 266.95B |
| Hansoh Pharmaceutical Group Company | 222.18B |
| WuXi Biologics | 132.35B |
| Innovent Biologics | 131.21B |
| Sino Biopharmaceutical | 112.27B |
| Akeso | 102.52B |
| CSPC Pharmaceutical Group | 97.18B |
| Sichuan Kelun-Biotech Biopharmaceutical | 93.09B |